Publication | Closed Access

The antifibrotic effect of pheretima protein is mediated by the TGF-β1/Smad2/3 pathway and attenuates inflammation in bleomycin-induced idiopathic pulmonary fibrosis

InflammationAntifibrotic EffectFibrosisAntifibrotic TherapyInflammatory Lung DiseaseTgf-β1/smad2/3 PathwayLung InflammationImmunologyPathologyPulmonary PharmacologyPulmonary FibrosisPheretima ProteinMedicineCell BiologyPulmonary Disease